Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nipa Biocides, originally operating as Nipa Laboratories, is a specialist manufacturer of antimicrobial preservatives and biocides for the pharmaceutical, personal care, and industrial sectors. The company is globally recognized for its "Nipa" range of parabens, including methylparaben (Nipagin) and propylparaben (Nipasol), which are essential for preventing microbial growth in topical formulations and liquid medicines. Founded in 1939 in the United Kingdom, Nipa became a leader in preservation technology before being acquired by Clariant in 2000 as part of the BTP plc acquisition. Today, the Nipa brand remains a cornerstone of Clariant's Care Chemicals portfolio, providing high-purity chemical solutions for healthcare and consumer products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NIPA Biocides.